Clinical Trials Directory

Trials / Completed

CompletedNCT03536832

Subcuticular Skin Closure at Cesarean Delivery

Comparison of Suture Materials for Subcuticular Skin Closure at Cesarean Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Subcuticular skin closure with suture after cesarean has been shown to result in lower rates of wound complications than with staple closure. However, the optimal choice of suture material for subcuticular skin closure is unclear. Vicryl vs Prolen suture materials will be used for subcuticular closure of transverse skin incisions after cesarean section. Patients will be controlled for superficial surgical site infections 1 week after the cesarean section.

Detailed description

Cesarean section is the most common abdominal surgery worldwide. Subcuticular skin closure with suture after cesarean has been shown to result in lower rates of wound complications than with staple closure. However, the optimal choice of suture material for subcuticular skin closure is unclear. Vicryl vs Prolen suture materials will be used for subcuticular closure of transverse skin incisions after cesarean section. Patients will be controlled for superficial surgical site infections 1 week after the cesarean section.

Conditions

Interventions

TypeNameDescription
PROCEDURECesarean Section with VicrylPfnannenstiel incision will be done under general or spinal anaesthesia. The abdomen will be opened and fetus and plasenta will be delivered. Then abdomen will be closed. Skin will be closed with Vicryl.
PROCEDURECesarean Section with ProlenPfnannenstiel incision will be done under general or spinal anaesthesia. The abdomen will be opened and fetus and plasenta will be delivered. Then abdomen will be closed. Skin will be closed with prolen.

Timeline

Start date
2018-04-15
Primary completion
2018-10-15
Completion
2018-11-01
First posted
2018-05-25
Last updated
2018-11-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03536832. Inclusion in this directory is not an endorsement.